The JSE may benefit from firmer higher Asian markets on Friday morning, with sentiment boosted by news drugmaker Pfizer may get regulatory approval for a Covid-19 vaccine as early as October.

“This is not only for market concerns, but this is a world desperately anxious for a cure to put an end to the most severe global recession since the 1930s and so people can start to piece their lives back together,” said AxiCorp chief global markets strategist Stephen Innes in a note...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.